The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression

Y 染色体在膀胱肿瘤发生、生长和进展中的作用

基本信息

  • 批准号:
    10629079
  • 负责人:
  • 金额:
    $ 54.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT 2 – SUMMARY Loss of the Y chromosome (LOY) is associated with increased risk of cancer development and death in men with several cancer types. In bladder cancer (BC), a tobacco related malignancy, LOY is seen in ~30% of tumors, yet the biological relevance of this is unknown. Here we address this Knowledge Gap with the Objective to define the molecular mechanisms responsible for LOY driven growth and progression and have Impact by translating these into effective interventions for bladder and other cancer types. Preliminary Data: We examined TCGA BC RNAseq dataset using an LOY gene signature we developed, and found low signature scores associated with reduced patient survival following surgery. To determine if LOY drives BC growth, we developed lineage related male murine cell lines with (Y+) or w/o (Y-) Y chromosome. Y- tumors grew faster than Y+ tumors in immunocompetent mice and cytometric profiling found the former to have increased immunosuppressive tumor-associated macrophages, CD8+ T cells with exhausted phenotype while latter had increased NK cells. In mice (Rag2-/-;Il2rg-/-) that are devoid of T, B and NK cells, Y+ and Y- tumors grew similarly. Transcriptional profiling found four Y chromosome genes differentially expressed in these tumor types, with chromatin organization genes Uty and Kdm5d being the only ones whose expression stratified outcome in TCGA BC patients. Thus, we genetically deleted these genes in Y+ cells and found enhanced tumor growth only in immunocompetent mice while their overexpression in Y- cells reduced their growth. Hence, we test the Hypothesis that Uty and Kdm5d loss enhance BC growth and progression via creation of an immunosuppressive tumor microenvironment in three Specific Aims. In Aim 1 we determine role of Uty and Kdm5d in tumor development and progression using full and urothelial specific conditional Kdm5d or Uty null mice be exposed to the chemical carcinogen BBN. With Project 3 we test the hypothesis that Uty and its X chromosome paralog Utx (aka, Kdm6a) have independent suppressive effects on BC formation and progression by crossing full and urothelial specific conditional Uty and Utx null mice and exposing them to BBN. In Aim 2 we define how Kdm5d and Uty suppress BC and the role of the immune system in this process using defined LOF functional mutants to define the regions on these proteins responsible for tumor growth suppression. With Project 1, we use spatial proteomics to examine immunological infiltrates in relation to mutant and WT Kdm5d and Uty cancer cell expression and various knockout mice or antibody depletion strategy to define which cellular components of the immune system drive tumor growth differences. In Aim 3 we examine ANPEP, the most upregulated gene in Y- tumors that is also a poor prognostic in BC patients and druggable target, as a candidate autosomal effector gene driving Y- tumor growth. We found Y- tumors are more responsive than Y+ tumors to anti-PD-1 and ANPEP depletion in Y- cells made tumors more sensitive to anti-PD-1. Here we will examine the impact of ANPEP deletion or pharmacologic inhibition on the efficacy of anti-PD-1 immune checkpoint blockade therapy.
项目2 -概要 Y染色体丢失(LOY)与男性癌症发展和死亡风险增加有关 几种癌症类型。在膀胱癌(BC)中,烟草相关的恶性肿瘤,LOY见于约30%的肿瘤中, 但其生物学意义尚不清楚。在这里,我们解决这个知识差距的目标, 定义负责LOY驱动生长和进展的分子机制,并通过以下方式产生影响: 将这些转化为膀胱和其他癌症类型的有效干预措施。初步数据:我们检查了 使用我们开发的LOY基因签名的TCGA BC RNAseq数据集,发现签名得分较低 与手术后患者存活率降低相关。为了确定LOY是否推动BC增长,我们开发了 具有(Y+)或w/o(Y-)Y染色体的谱系相关雄性鼠细胞系。Y-肿瘤比Y+肿瘤生长更快 在免疫功能正常的小鼠中,细胞计数分析发现前者具有增加的免疫抑制作用, 肿瘤相关的巨噬细胞,CD 8 + T细胞具有耗尽的表型,而后者具有增加的NK细胞。在 缺乏T、B和NK细胞的小鼠(Rag 2-/-; Il 2 rg-/-),Y+和Y-肿瘤生长相似。转录谱 发现四个Y染色体基因在这些肿瘤类型中差异表达,染色质组织基因 Uty和Kdm 5d是TCGA BC患者中唯一表达分层的结果。因此我们 在Y+细胞中基因删除了这些基因,并发现只有在免疫活性小鼠中肿瘤生长增强 而它们在Y细胞中的过度表达则降低了它们的生长。因此,我们检验了Uty和Kdm 5d 免疫抑制性肿瘤微环境的产生增强了BC的生长和进展 三个具体目标。在目的1中,我们确定Uty和Kdm 5d在肿瘤发生和进展中的作用 使用完全和尿路上皮特异性条件性Kdm 5d或Uty缺失小鼠暴露于化学致癌物BBN。 在项目3中,我们测试了Uty及其X染色体伴侣Utx(aka,Kdm 6a) 通过完全和尿路上皮特异性交叉对BC形成和进展的独立抑制作用 条件性Uty和Utx缺失小鼠并将它们暴露于BBN。在目标2中,我们定义Kdm 5d和Uty如何抑制 BC和免疫系统在此过程中的作用,使用定义的LOF功能突变体来定义区域 这些负责抑制肿瘤生长的蛋白质。在项目1中,我们使用空间蛋白质组学, 检查与突变型和WT Kdm 5d和Uty癌细胞表达相关的免疫浸润, 各种敲除小鼠或抗体耗竭策略,以确定免疫系统的哪些细胞成分 驱动肿瘤生长的差异。在目标3中,我们检测了ANPEP,它是Y型肿瘤中上调最多的基因, 也是BC患者的不良预后和药物靶点,作为驱动Y染色体的候选常染色体效应基因, 肿瘤生长我们发现Y-肿瘤比Y+肿瘤对Y-肿瘤中的抗PD-1和ANPEP消耗更敏感。 细胞使肿瘤对抗PD-1更敏感。在这里,我们将研究ANPEP删除或 抗PD-1免疫检查点阻断疗法的功效的药理学抑制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAN THEODORESCU其他文献

DAN THEODORESCU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAN THEODORESCU', 18)}}的其他基金

BLADDER TISSUE BANK
膀胱组织库
  • 批准号:
    8167199
  • 财政年份:
    2010
  • 资助金额:
    $ 54.31万
  • 项目类别:
Understanding the AGL metastasis suppressor for therapeutic gain
了解 AGL 转移抑制因子的治疗效果
  • 批准号:
    9223676
  • 财政年份:
    2010
  • 资助金额:
    $ 54.31万
  • 项目类别:
Understanding the AGL metastasis suppressor for therapeutic gain
了解 AGL 转移抑制因子的治疗效果
  • 批准号:
    9030867
  • 财政年份:
    2010
  • 资助金额:
    $ 54.31万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7728883
  • 财政年份:
    2008
  • 资助金额:
    $ 54.31万
  • 项目类别:
Signaling and Progression in Prostate Cancer
前列腺癌的信号传导和进展
  • 批准号:
    7115394
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Core B
核心B
  • 批准号:
    8744397
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Core B
核心B
  • 批准号:
    8744375
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Signaling and Progression in Prostate Cancer
前列腺癌的信号传导和进展
  • 批准号:
    7284160
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Project 1
项目1
  • 批准号:
    8916609
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Signaling and Progression in Prostate Cancer
前列腺癌的信号传导和进展
  • 批准号:
    7485768
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:

相似海外基金

Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
  • 批准号:
    DP240100640
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
  • 批准号:
    23K01889
  • 财政年份:
    2023
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10452217
  • 财政年份:
    2022
  • 资助金额:
    $ 54.31万
  • 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10670838
  • 财政年份:
    2022
  • 资助金额:
    $ 54.31万
  • 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
  • 批准号:
    DP200100492
  • 财政年份:
    2020
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
  • 批准号:
    407264
  • 财政年份:
    2019
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
  • 批准号:
    18K18240
  • 财政年份:
    2018
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
  • 批准号:
    17K12379
  • 财政年份:
    2017
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
  • 批准号:
    17K13937
  • 财政年份:
    2017
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
  • 批准号:
    8742767
  • 财政年份:
    2014
  • 资助金额:
    $ 54.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了